Recombinant Human Erythropoietin

Name: Recombinant Human Erythropoietin
Brand: PATHGENE PHARMA DISTRIBUTORS
Price: 250 INR
Availability: InStock

Price 250 INR/ Piece

Get a Price/Quote

MOQ : 10 Pieces

Recombinant Human Erythropoietin Specification

Salt Composition
Epoetin Alfa

Packaging Type
Pre-filled syringe

Life Span
As per expiry date

Pacakaging (Quantity Per Box)
1 PFS

Brand Name
Renocrit

Origin of Medicine
India

Indication
CKD Anaemia

Dosage Form
Injection

Drug Type
Biological

Ingredients
Epoetin Alfa

Physical Form
Injection

Function
Stimulates erythropoiesis

Recommended For
CKD Anaemia

Dosage
4000 IU

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
Single PFS

Storage Instructions
2-8C

No Preservative
Yes

Temperature Sensitive
Yes

Concentration
4000 IU/0.4 ml

Molecule Name
Recombinant human erythropoietin

Administration Route
Subcutaneous

Recombinant Human Erythropoietin Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Pieces Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Recombinant Human Erythropoietin

Buy Renocrit Recombinant Human Erythropoietin at an unbeatable price, ensuring spectacular value in every dose. This grand therapeutic solution, featuring 4000 IU/0.4 ml concentration, is meticulously engineered for adults with CKD anaemia. The gorgeous, preservative-free pre-filled syringe guarantees safety, convenience, and top-tier efficacy for stimulating erythropoiesis. Sourced in India and trusted by medical professionals, the single PFS packaging preserves the temperature-sensitive quality, promising consistent performance. Choose Renocrit for a superior, reliable biological option, designed for optimal storage at 2-8C and administered subcutaneously for targeted results.

Versatile Application and Effective Method

Recombinant Human Erythropoietin (Epoetin Alfa) is predominantly used in healthcare settings such as hospitals and clinics for the treatment of CKD anaemia in adults. The application method is via subcutaneous injection, maximizing absorption and efficacy. It is not suitable for plant or agricultural uses, being exclusively a biopharmaceutical solution. Physicians direct dosage and administration, ensuring each patient receives personalized care optimally targeting erythropoiesis stimulation for improved red blood cell production.

Main Market Reach and Fast Delivery

Renocrit's main domestic market is India, catering to numerous hospitals and clinics nationwide. The product promises the lowest price and swift arrival through a dependable supply chain. With dedicated exporters, it is also handed over quickly to international clients, reaching global destinations efficiently. Typical delivery time is coordinated for timely availability, ensuring every Renocrit pre-filled syringe is ready when and where needed, promising uninterrupted care for CKD anaemia patients.

FAQ's of Recombinant Human Erythropoietin:

Q: How should Recombinant Human Erythropoietin Renocrit be stored?

A: It should be stored between 2-8C, as it is temperature sensitive. Avoid freezing and keep away from direct light.

Q: What is the correct method for administering Renocrit?

A: Renocrit is administered via subcutaneous injection, following the dosage guidelines provided by a physician.

Q: When should Renocrit be used?

A: Renocrit is recommended when treating anaemia associated with chronic kidney disease (CKD) in adults, as prescribed by your healthcare provider.

Q: Where is Renocrit produced and widely supplied?

A: Renocrit is manufactured in India and supplied both domestically and internationally, reaching clinics and hospitals globally.

Q: What are the main benefits of using Recombinant Human Erythropoietin?

A: Its main benefit is effectively stimulating erythropoiesis, improving red blood cell count in CKD anaemia patients, and supporting better health outcomes.